These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23376083)

  • 41. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism.
    Lenart M; Trzyna E; Rutkowska M; Bukowska-Strakova K; Szaflarska A; Pituch-Noworolska A; Szczepanik A; Zembala M; Siedlar M
    Int J Mol Med; 2010 Sep; 26(3):435-42. PubMed ID: 20664961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
    Cooper DL; Martin SG; Robinson JI; Mackie SL; Charles CJ; Nam J; ; Isaacs JD; Emery P; Morgan AW
    PLoS One; 2012; 7(1):e28918. PubMed ID: 22235253
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Moraru M; Perez-Portilla A; Al-Akioui Sanz K; Blazquez-Moreno A; Arnaiz-Villena A; Reyburn HT; Vilches C
    Front Immunol; 2021; 12():615645. PubMed ID: 34108956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Influence of FcγRIIIa polymorphism on rituximab-dependent NK cell-mediated cytotoxicity to Raji cells].
    Qu YH; Li Y; Wu YF; Fang JP; Huang SL; Huang Y; Wei J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1269-74. PubMed ID: 21129274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Terminal Effector CD8 T Cells Defined by an IKZF2
    Naluyima P; Lal KG; Costanzo MC; Kijak GH; Gonzalez VD; Blom K; Eller LA; Creegan M; Hong T; Kim D; Quinn TC; Björkström NK; Ljunggren HG; Serwadda D; Katabira ET; Sewankambo NK; Gray RH; Baeten JM; Michael NL; Wabwire-Mangen F; Robb ML; Bolton DL; Sandberg JK; Eller MA
    J Immunol; 2019 Oct; 203(8):2210-2221. PubMed ID: 31519862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity.
    Moroi R; Endo K; Kinouchi Y; Shiga H; Kakuta Y; Kuroha M; Kanazawa Y; Shimodaira Y; Horiuchi T; Takahashi S; Shimosegawa T
    Immunogenetics; 2013 Apr; 65(4):265-71. PubMed ID: 23358932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56
    Lajoie L; Congy-Jolivet N; Bolzec A; Thibault G
    Front Immunol; 2017; 8():1556. PubMed ID: 29209315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations.
    Picton AC; Paximadis M; Tiemessen CT
    Infect Genet Evol; 2010 May; 10(4):487-94. PubMed ID: 20206716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
    Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
    J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck.
    Taylor RJ; Chan SL; Wood A; Voskens CJ; Wolf JS; Lin W; Chapoval A; Schulze DH; Tian G; Strome SE
    Cancer Immunol Immunother; 2009 Jul; 58(7):997-1006. PubMed ID: 18979096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of CD16a, the surface receptor of Kupffer cells, on the growth of hepatocellular carcinoma cells.
    Li XY; Wu L; Li SW; Zhou WB; Wang MY; Zuo GQ; Liu CA; Ding X
    Int J Mol Med; 2016 Jun; 37(6):1465-74. PubMed ID: 27082928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in C-C chemokine receptor type 5 (CCR5) in South African individuals.
    Barmania F; Potgieter M; Pepper MS
    Int J Infect Dis; 2013 Dec; 17(12):e1148-53. PubMed ID: 23911155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of FcγRIIIa-158V/F with systemic lupus erythematosus in a Chinese population.
    Dai M; Zhou Z; Wang X; Qian X; Huang X
    Int J Rheum Dis; 2013 Dec; 16(6):685-91. PubMed ID: 24131500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased ITGAM and FcγRIIIA mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Zhou M; Li LH; Peng H; Li R; Feng CC; Xu WD; Leng RX; Pan HF; Ye DQ
    Clin Exp Med; 2014 Aug; 14(3):269-74. PubMed ID: 23708937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accurate interrogation of FCGR3A rs396991 in European and Asian populations using a widely available TaqMan genotyping method.
    Murphy KE; Niederer HA; King KS; Harris EC; Glass SM; Cox CJ
    Pharmacogenet Genomics; 2015 Nov; 25(11):569-72. PubMed ID: 26367501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.
    Srivastava RM; Lee SC; Andrade Filho PA; Lord CA; Jie HB; Davidson HC; López-Albaitero A; Gibson SP; Gooding WE; Ferrone S; Ferris RL
    Clin Cancer Res; 2013 Apr; 19(7):1858-72. PubMed ID: 23444227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease.
    Rohatgi S; Gohil S; Kuniholm MH; Schultz H; Dufaud C; Armour KL; Badri S; Mailliard RB; Pirofski LA
    mBio; 2013 Aug; 4(5):e00573-13. PubMed ID: 23982074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of high-affinity anti-CD16A allotype-independent human antibody domains.
    Li W; Yang H; Dimitrov DS
    Exp Mol Pathol; 2016 Oct; 101(2):281-289. PubMed ID: 27712994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing.
    Mota G; Moldovan I; Calugaru A; Hirt M; Kozma E; Galatiuc C; Brasoveanu L; Boltz-Nitulescu G
    Scand J Immunol; 2004 Mar; 59(3):278-84. PubMed ID: 15030579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of a quantitative Real-Time PCR assay and droplet digital PCR for copy number analysis of the CCL4L genes.
    Bharuthram A; Paximadis M; Picton AC; Tiemessen CT
    Infect Genet Evol; 2014 Jul; 25():28-35. PubMed ID: 24727646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.